Şermin Çoban
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Şermin Çoban has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Gökhan Atay
Department of Nephrology Izmir Bakircay University İzmir Turkey
2 shared publications - Hakan Ozer
Department of Nephrology Izmir Bakircay University İzmir Turkey
2 shared publications - Hafize Irem Demir
Department of Internal Medicine Izmir Bakircay University İzmir Turkey
1 shared publication - Neslişah Rakıcıoğlu
Department of Nutrition and Dietetics, Faculty of Health Sciences, Hacettepe University
1 shared publication - Rüveyda Esra Özkalaycı
Department of Nutrition and Dietetics, Faculty of Health Sciences, Recep Tayyip Erdogan University, 53100 Rize, Türkiye
1 shared publication - Yasin Öztürk
Department of Nephrology, Bülent Ecevit University, 67100 Zonguldak, Türkiye
1 shared publication
Latest Publications
- 27 August 2026
- Published by Wiley in Diabetic Medicine
- Vol. 43 (10) , e70455
Renal outcomes following fundus fluorescein angiography in patients with diabetic nephropathy: Incidence, risk factors and three‐month kidney function changes
Aims: The aim of this study was to determine the incidence of contrast‐associated acute kidney injury (CA‐AKI) after fundus fluorescein angiography (FFA) in a high‐risk diabetic nephropathy (DN) population, to identify clinical predictors of renal injury and to evaluate the effect of acute exacerbation on 3‐month eGFR changes. Methods: This retrospective cohort study included 307 patients diagnosed with DN. CA‐AKI was defined as an increase of ≥0.3 mg/dL in serum creatinine level within 48 h or ≥1.5‐fold increase within 7 days after FFA exposure. Patients' medication history and 3‐month post‐procedure eGFR values were recorded. Independent factors predicting CA‐AKI development were assessed using multivariate logistic regression, while long‐term losses were evaluated using linear regression and ROC analysis. Results: CA‐AKI occurred in 5.2% of patients. Lower baseline eGFR and diuretic use were independent predictors of CA‐AKI. ROC analysis identified a baseline eGFR threshold of ≤32 mL/min/1.73 m 2 for increased CA‐AKI risk, and a combined model including eGFR and diuretic use demonstrated superior predictive accuracy. Although SGLT‐2 inhibitor use was associated with CA‐AKI in univariate analysis, it was not independently significant after adjustment. Notably, 13 of 16 patients (81.3%) who developed CA‐AKI experienced persistent eGFR decline at 3 months, and CA‐AKI was the strongest predictor of subsequent renal function deterioration. Conclusions: FFA is associated with a clinically meaningful risk of CA‐AKI in patients with advanced DN, particularly in those with eGFR ≤32 mL/min/1.73 m 2 and concurrent diuretic therapy. Careful pre‐procedural risk stratification, individualized hydration and post‐procedure renal monitoring are warranted.
- 27 August 2026
- Published by Wiley in Diabetic Medicine
- Vol. 43 (10) , e70455
Renal outcomes following fundus fluorescein angiography in patients with diabetic nephropathy: Incidence, risk factors and three‐month kidney function changes
Aims: The aim of this study was to determine the incidence of contrast‐associated acute kidney injury (CA‐AKI) after fundus fluorescein angiography (FFA) in a high‐risk diabetic nephropathy (DN) population, to identify clinical predictors of renal injury and to evaluate the effect of acute exacerbation on 3‐month eGFR changes. Methods: This retrospective cohort study included 307 patients diagnosed with DN. CA‐AKI was defined as an increase of ≥0.3 mg/dL in serum creatinine level within 48 h or ≥1.5‐fold increase within 7 days after FFA exposure. Patients' medication history and 3‐month post‐procedure eGFR values were recorded. Independent factors predicting CA‐AKI development were assessed using multivariate logistic regression, while long‐term losses were evaluated using linear regression and ROC analysis. Results: CA‐AKI occurred in 5.2% of patients. Lower baseline eGFR and diuretic use were independent predictors of CA‐AKI. ROC analysis identified a baseline eGFR threshold of ≤32 mL/min/1.73 m 2 for increased CA‐AKI risk, and a combined model including eGFR and diuretic use demonstrated superior predictive accuracy. Although SGLT‐2 inhibitor use was associated with CA‐AKI in univariate analysis, it was not independently significant after adjustment. Notably, 13 of 16 patients (81.3%) who developed CA‐AKI experienced persistent eGFR decline at 3 months, and CA‐AKI was the strongest predictor of subsequent renal function deterioration. Conclusions: FFA is associated with a clinically meaningful risk of CA‐AKI in patients with advanced DN, particularly in those with eGFR ≤32 mL/min/1.73 m 2 and concurrent diuretic therapy. Careful pre‐procedural risk stratification, individualized hydration and post‐procedure renal monitoring are warranted.
- 17 June 2026
- Published by Dahiliye uzmanlari dernegi (DAHUDER) in DAHUDER Medical Journal
- Vol. 6 (Advanced O) , 73-79
Association of Low-Grade Proteinuria with Arterial Stiffness in Early-Stage Autosomal Dominant Polycystic Kidney Disease
Objective: Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a systemic ciliopathy characterized by progressive renal cyst formation and an increased risk of early cardiovascular morbidity. Arterial stiffness has been demonstrated in ADPKD even before the development of hypertension. However, the independent contribution of low-grade proteinuria to vascular dysfunction in normotensive patients with preserved renal function remains insufficiently characterized. We aimed to evaluate the association between proteinuria and arterial stiffness parameters in normotensive patients with early-stage ADPKD.Methods: In this cross-sectional case–control study, 20 normotensive ADPKD patients and 19 healthy controls were included. Individuals with diabetes mellitus, smoking history, cardiovascular disease, or antihypertensive medication use were excluded. Arterial stiffness parameters, including pulse wave velocity (PWV) and augmentation index (AIx), were assessed using an oscillometric device. ADPKD patients were stratified according to 24-hour urinary protein excretion: non-proteinuric (0.05), indicating that vascular impairment in early ADPKD may be independent of significant renal function decline.Conclusion: Arterial stiffness is increased in normotensive patients with early-stage ADPKD, independent of hypertension. Moreover, even low-grade proteinuria (150-1000 mg/day) is associated with greater impairment in both large-artery stiffness and peripheral wave reflection parameters. These findings suggest that proteinuria may serve as an early marker of subclinical vascular dysfunction in ADPKD.
- 17 June 2026
- Published by Dahiliye uzmanlari dernegi (DAHUDER) in DAHUDER Medical Journal
- Vol. 6 (Advanced O) , 73-79
Association of Low-Grade Proteinuria with Arterial Stiffness in Early-Stage Autosomal Dominant Polycystic Kidney Disease
Objective: Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a systemic ciliopathy characterized by progressive renal cyst formation and an increased risk of early cardiovascular morbidity. Arterial stiffness has been demonstrated in ADPKD even before the development of hypertension. However, the independent contribution of low-grade proteinuria to vascular dysfunction in normotensive patients with preserved renal function remains insufficiently characterized. We aimed to evaluate the association between proteinuria and arterial stiffness parameters in normotensive patients with early-stage ADPKD.Methods: In this cross-sectional case–control study, 20 normotensive ADPKD patients and 19 healthy controls were included. Individuals with diabetes mellitus, smoking history, cardiovascular disease, or antihypertensive medication use were excluded. Arterial stiffness parameters, including pulse wave velocity (PWV) and augmentation index (AIx), were assessed using an oscillometric device. ADPKD patients were stratified according to 24-hour urinary protein excretion: non-proteinuric (0.05), indicating that vascular impairment in early ADPKD may be independent of significant renal function decline.Conclusion: Arterial stiffness is increased in normotensive patients with early-stage ADPKD, independent of hypertension. Moreover, even low-grade proteinuria (150-1000 mg/day) is associated with greater impairment in both large-artery stiffness and peripheral wave reflection parameters. These findings suggest that proteinuria may serve as an early marker of subclinical vascular dysfunction in ADPKD.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista de Nutrição
- Vol. 37, e220069
Dietary total antioxidant capacity, cardiovascular risk, and anthropometric obesity indices in hemodialysis patients: A case-control study
Objective: Oxidative stress is triggered by malnutrition and antioxidant losses due to dialysis in hemodialysis patients and thus, oxidative stress increases the risk of mortality in patients with cardiovascular disease and obesity. The study aims to determine differences in cardiovascular risk scores and obesity indices between hemodialysis and control groups and to examine the relationship between the tertiles of dietary total antioxidant capacity with cardiovascular risk, and obesity in hemodialysis and control groups. Methods: This is a cross-sectional case-control study involving hemodialysis patients (n=46) and healthy individuals (n=46). Participants’ general characteristics were obtained via a questionnaire, and the Framingham Risk Score was calculated. The dietary total antioxidant capacity was calculated using two methods based on a seven-day food record. Obesity indices, such as Basal Metabolism Index and Body Shape Index, were calculated using anthropometric measurements. Results: The mean age of the participants was 51.1±10.4 years. In the hemodialysis group, obesity indices including body weight, Basal Metabolism Index, waist circumference, fat mass index, and fat-free mass index were lower, while Framingham Risk Score values were higher than the control group (p<0.05). Energy-adjusted dietary total antioksidant capacity values were lower in hemodialysis group, and most patients were in the low tertiles of Trolox equivalent antioxidant capacity, total radical-trapping antioxidant parameter, ferric reducing-antioxidant power and vitamin C equivalent antioxidant capacity (p<0.05). Conclusion: Providing hemodialysis patients with a healthy diet can increase the dietary total antioxidant capacity, and potentially reduce cardiovascular risk, and obesity indices.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista de Nutrição
- Vol. 37, e220069
Open AccessDietary total antioxidant capacity, cardiovascular risk, and anthropometric obesity indices in hemodialysis patients: A case-control study
Objective: Oxidative stress is triggered by malnutrition and antioxidant losses due to dialysis in hemodialysis patients and thus, oxidative stress increases the risk of mortality in patients with cardiovascular disease and obesity. The study aims to determine differences in cardiovascular risk scores and obesity indices between hemodialysis and control groups and to examine the relationship between the tertiles of dietary total antioxidant capacity with cardiovascular risk, and obesity in hemodialysis and control groups. Methods: This is a cross-sectional case-control study involving hemodialysis patients (n=46) and healthy individuals (n=46). Participants’ general characteristics were obtained via a questionnaire, and the Framingham Risk Score was calculated. The dietary total antioxidant capacity was calculated using two methods based on a seven-day food record. Obesity indices, such as Basal Metabolism Index and Body Shape Index, were calculated using anthropometric measurements. Results: The mean age of the participants was 51.1±10.4 years. In the hemodialysis group, obesity indices including body weight, Basal Metabolism Index, waist circumference, fat mass index, and fat-free mass index were lower, while Framingham Risk Score values were higher than the control group (p<0.05). Energy-adjusted dietary total antioksidant capacity values were lower in hemodialysis group, and most patients were in the low tertiles of Trolox equivalent antioxidant capacity, total radical-trapping antioxidant parameter, ferric reducing-antioxidant power and vitamin C equivalent antioxidant capacity (p<0.05). Conclusion: Providing hemodialysis patients with a healthy diet can increase the dietary total antioxidant capacity, and potentially reduce cardiovascular risk, and obesity indices.